Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Adamec

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis and Related Disorders|July 23, 2018
Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosisIvan Adamec, Ivan Pavlović, Tin Pavičić, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Delay in the diagnosis of multiple sclerosis in CroatiaIvan Adamec, Barbara Barun, Tereza Gabelić, et al.
Acta Neurologica Belgica|March 20, 2012
Sick sinus syndrome and orthostatic hypotension in Parkinson's diseaseIvan Adamec, Nataša Klepac, Iva Milivojević, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 11, 2014
Evaluation of brainstem involvement in multiple sclerosisMagdalena Krbot Skorić, Ivan Adamec, Vesna Nesek Mađarić, et al.
Cureus|August 29, 2022
New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 VaccineAna Abicic, Barbara Sitas, Ivan Adamec, et al.
Journal of Neuroimmunology|December 18, 2021
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumabIvan Adamec, Dunja Rogić, Monika-Gabriele Penz, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
Multiple brain cysts: an unusual form of demyelinating diseaseMario Habek, Ivan Adamec, Kamelija Zarković, et al.
Clinical EEG and Neuroscience|March 29, 2013
Tongue somatosensory-evoked potentials: evaluation of the afferent trigeminal pathway in patients with early multiple sclerosisTereza Gabelić, Magdalena Krbot Skorić, Ivan Adamec, et al.
Journal of the Neurological Sciences|November 7, 2012
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosisIvan Adamec, Ivo Bach, Anabella Karla Barušić, et al.
Human Vaccines & Immunotherapeutics|October 20, 2021
Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosisTereza Gabelić, Barbara Barun, Ivan Adamec, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis and Related Disorders|July 23, 2018
Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosisIvan Adamec, Ivan Pavlović, Tin Pavičić, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Delay in the diagnosis of multiple sclerosis in CroatiaIvan Adamec, Barbara Barun, Tereza Gabelić, et al.
Acta Neurologica Belgica|March 20, 2012
Sick sinus syndrome and orthostatic hypotension in Parkinson's diseaseIvan Adamec, Nataša Klepac, Iva Milivojević, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 11, 2014
Evaluation of brainstem involvement in multiple sclerosisMagdalena Krbot Skorić, Ivan Adamec, Vesna Nesek Mađarić, et al.
Cureus|August 29, 2022
New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 VaccineAna Abicic, Barbara Sitas, Ivan Adamec, et al.
Journal of Neuroimmunology|December 18, 2021
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumabIvan Adamec, Dunja Rogić, Monika-Gabriele Penz, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 23, 2011
Multiple brain cysts: an unusual form of demyelinating diseaseMario Habek, Ivan Adamec, Kamelija Zarković, et al.
Clinical EEG and Neuroscience|March 29, 2013
Tongue somatosensory-evoked potentials: evaluation of the afferent trigeminal pathway in patients with early multiple sclerosisTereza Gabelić, Magdalena Krbot Skorić, Ivan Adamec, et al.
Journal of the Neurological Sciences|November 7, 2012
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosisIvan Adamec, Ivo Bach, Anabella Karla Barušić, et al.
Human Vaccines & Immunotherapeutics|October 20, 2021
Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosisTereza Gabelić, Barbara Barun, Ivan Adamec, et al.
Pageof 13